4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-006326
CEO sold 5,990 shares at $3.34 ($19,995)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Sale : show line 1 in the form | −5,990 | $3.34 | $19,995 | 1,046,055 | D |
| Open-market sales · 5,990 sh · avg $3.34 · $19,995 | ||||||
Loading xslF345X05/form4.xml…